Development
Acrivon Therapeutics, Inc.
ACRV
$1.35
$0.108.00%
NASDAQ
| 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 142.09M | 150.95M | 120.21M | 127.75M | 76.82M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 2.40M | 2.33M | 3.75M | 4.34M | 1.85M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 144.49M | 153.28M | 123.96M | 132.10M | 78.67M |
|
|
|||||
| Total Current Assets | 144.49M | 153.28M | 123.96M | 132.10M | 78.67M |
| Net Property, Plant & Equipment | 6.19M | 6.36M | 6.57M | 6.86M | 7.11M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 411.00K | 408.00K | 388.00K | 388.00K | 1.93M |
| Total Assets | 151.09M | 160.05M | 170.20M | 181.23M | 87.71M |
|
|
|||||
| Total Accounts Payable | 1.50M | 1.27M | 1.37M | 904.00K | 1.98M |
| Total Accrued Expenses | 7.02M | 5.00M | 3.57M | 4.14M | 2.67M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 776.00K | 753.00K | 740.00K | 726.00K | 717.00K |
| Total Finance Division Other Current Liabilities | -- | -- | -- | 742.00K | 1.02M |
| Total Other Current Liabilities | -- | -- | -- | 742.00K | 1.02M |
| Total Current Liabilities | 9.30M | 7.02M | 5.68M | 6.52M | 6.39M |
|
|
|||||
| Total Current Liabilities | 9.30M | 7.02M | 5.68M | 6.52M | 6.39M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 3.64M | 3.85M | 4.05M | 4.24M | 4.42M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 12.94M | 10.87M | 9.73M | 10.75M | 10.81M |
|
|
|||||
| Common Stock & APIC | 235.62M | 232.31M | 229.25M | 226.60M | 1.62M |
| Retained Earnings | -97.17M | -82.70M | -68.79M | -56.03M | -47.10M |
| Treasury Stock & Other | -302.00K | -427.00K | 9.00K | -95.00K | -133.00K |
| Total Common Equity | 138.15M | 149.18M | 160.47M | 170.48M | -45.62M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | 122.52M |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | 122.52M |
|
|
|||||
| Total Common Equity | 138.15M | 149.18M | 160.47M | 170.48M | -45.62M |
| Total Preferred Equity | -- | -- | -- | -- | 122.52M |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 138.15M | 149.18M | 160.47M | 170.48M | 76.90M |
|
|
|||||